- Oxford Biomedica PLC oxford Biomedica to host webinar showcasing the TetraVectaTM system TranscriptOct 02, 2023
- Half Year 2023 Oxford Biomedica PLC Earnings Call TranscriptSep 20, 2023$3.49 (+11.86%)Earnings
- Full Year 2022 Oxford Biomedica PLC Earnings Call TranscriptApr 25, 2023$5.53Earnings
- Oxford Biomedica PLC at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Half Year 2022 Oxford BioMedica PLC Earnings Call TranscriptSep 15, 2022$5.21 (+0.29%)Earnings
- Full Year 2021 Oxford BioMedica PLC Earnings Call TranscriptApr 20, 2022$7.1 (-15.98%)Earnings
- Half Year 2021 Oxford BioMedica PLC Earnings Call TranscriptSep 22, 2021$22.64 (+17.82%)Earnings
- Full Year 2020 Oxford BioMedica PLC Earnings Call TranscriptApr 15, 2021$14.81 (+4.19%)Earnings
- Half Year 2020 Oxford BioMedica PLC Earnings Call TranscriptSep 17, 2020$11.24 (+2.18%)Earnings
- Oxford BioMedica PLC Annual Shareholders Meeting TranscriptJun 23, 2020
- Full Year 2019 Oxford BioMedica PLC Earnings Call TranscriptMay 06, 2020$8.93 (-2.40%)Earnings
- Half Year 2019 Oxford BioMedica PLC Earnings Call TranscriptSep 04, 2019$7.8Earnings
- Full Year 2018 Oxford BioMedica PLC Earnings Call TranscriptMar 14, 2019$9.15Earnings
Full Year 2021 Oxford BioMedica PLC Earnings Call Transcript
Good afternoon, ladies and gentlemen and welcome to the Oxford Biomedica Preliminary Results 2021 Conference Call. (Operator Instructions) As a reminder, today's conference call is being recorded.
Welcome, everybody, and thank you for joining us for our preliminary results 2021 conference call. I'm Sophia Bolhassan, Head of Investor Relations, and I'm joined here today by Roch Doliveux, Chairman and Interim Chief Executive Officer; Stuart Paynter, Chief Financial Officer; and Kyri Mitrophanous, Chief Scientific Officer.
I'll now hand over to Roch to begin the presentation.
Thank you very much, Sophia. And welcome everybody to the 2021 financial results for Oxford Biomedica. I will share with you a couple of slides on where is the company and then let Stuart highlight the financial results and Kyri and Stuart talk about the future.
First of all, I'm clearly delighted about the 2021
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)